TickerFacts.

Company research / MENS

Jyong Biotech Ltd. (MENS)

Build a valuation ↗↓ Download CSV

CIK 0001954488 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 20-F (annual report) · 2026-05-15

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2025-12-312024-12-312023-12-31
R&D Expense$813.0K$927.0K$1.07M
Operating Income-$2.61M-$2.06M-$2.80M
Depreciation & Amortization$100.0K$120.0K$127.0K
EBITDA-$2.51M-$1.94M-$2.67M
Net Income-$4.67M-$3.02M-$4.40M
EPS (Diluted)-$0.06-$0.04-$0.06
Total Assets$20.78M$6.37Mn/a
Total Liabilities$45.68M$42.88Mn/a
Long-Term Debt$2.12Mn/an/a
Shareholders' Equity-$24.91M-$36.52M-$34.07M
Operating Cash Flow-$3.04M-$3.62M-$2.60M
Shares Outstanding76.03M73.36Mn/a
Weighted Average Diluted Shares73.01M71.57M71.57M
EPS (Basic)-$0.06-$0.04-$0.06

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView